Sorafenib alone or as combination therapy for growth control of cholangiocarcinoma (Q40246733)
scientific article published on 5 January 2007
Language:
Current Data About Sorafenib alone or as combination therapy for growth control of cholangiocarcinoma
(P31) (Q13442814)
(P248)
(P698) 17266941
(P813) Monday, September 18, 2017

(P304) 1308-1317
(P248)
(P698) 17266941
(P813) Monday, September 18, 2017

(P407) (Q1860)

(P433) 9
(P248)
(P698) 17266941
(P813) Monday, September 18, 2017

(P478) 73
(P248)
(P698) 17266941
(P813) Monday, September 18, 2017

(P577) Friday, January 5, 2007
(P248)
(P698) 17266941
(P813) Monday, September 18, 2017

(P921) (Q124292)

(P1433) (Q864229)
(P248)
(P698) 17266941
(P813) Monday, September 18, 2017

(P1476) "Sorafenib alone or as combination therapy for growth control of cholangiocarcinoma" (language: en)
(P248)
(P698) 17266941
(P813) Monday, September 18, 2017

(P2093) Alexander Huether
(P1545) 1
(P248)
(P698) 17266941
(P813) Monday, September 18, 2017

Michael Höpfner
(P1545) 2
(P248)
(P698) 17266941
(P813) Monday, September 18, 2017

Viola Baradari
(P1545) 3
(P248)
(P698) 17266941
(P813) Monday, September 18, 2017

Detlef Schuppan
(P1545) 4
(P248)
(P698) 17266941
(P813) Monday, September 18, 2017

Hans Scherübl
(P1545) 5
(P248)
(P698) 17266941
(P813) Monday, September 18, 2017

other details
description scientific article published on 5 January 2007

External Links
(P356) 10.1016/J.BCP.2006.12.031
(P698) 17266941